NAC (Liver).

Glutathione is built from cysteine, glutamate and glycine, and cysteine and glycine are the two residues that most often run short. Supplying both lifts the synthesis rate more than either alone.

Glutamine feeds the glutamate residue of glutathione, completing the trio alongside the cysteine that NAC delivers.

Glutathione peroxidase carries selenium in its active site, so selenium is what allows newly made glutathione to neutralise peroxides in liver tissue.

Silymarin stabilises the hepatocyte membrane and supports glutathione levels by a different route than substrate supply. The two have been paired in liver formulas for decades.

Lipoic acid regenerates oxidised glutathione back to its active form and reduces cystine to usable cysteine. It multiplies the value of the cysteine NAC provides.

Ascorbate and glutathione regenerate each other in the cellular antioxidant network, so vitamin C spares the glutathione pool NAC helps build.

SAM-e is the liver's methyl donor and its breakdown feeds homocysteine into the transsulfuration route that produces cysteine. It reaches glutathione from the methylation side while NAC supplies cysteine directly.

Taurine is made from cysteine and is used to conjugate bile acids in the liver. NAC feeds the same sulfur pool that taurine synthesis draws on.

Sulfite oxidase, a molybdenum enzyme, handles the sulfite generated as cysteine is catabolised. A rising sulfur amino acid load makes molybdenum status relevant.

NAC raises glutathione by supplying its limiting precursor, whereas oral glutathione supplies the tripeptide itself. They reach the same pool from opposite ends.

The free thiol group of NAC binds copper and other divalent metals in the gut, which can lower their absorption when the two are taken together. This is an anti-synergy and separating the doses is the usual answer.

Sulfhydryl compounds bind zinc, so co-dosing NAC with zinc in the same capsule can reduce how much zinc is taken up. Formulators separate them for that reason.

The transsulfuration enzymes that produce the body's own cysteine both require pyridoxal phosphate. B6 keeps the endogenous route open alongside the cysteine NAC adds.

N-acetylcysteine is deacetylated by tissue acylases to release L-cysteine, which is the rate-limiting amino acid for glutathione synthesis. The two therefore feed the same pool rather than acting on different ones. Taking both raises cysteine availability by the same route and does not add a second mechanism.

Methionine is converted through homocysteine and cystathionine to cysteine by the transsulfuration pathway, which is the endogenous route to the same amino acid N-acetylcysteine supplies directly. When methionine intake is adequate and the pathway is running, the two inputs are partly interchangeable. The pairing is biochemical context for cysteine supply, not a demonstrated combined effect.

Methionine synthase needs methylcobalamin to remethylate homocysteine back to methionine, which sets how much homocysteine is available to enter transsulfuration toward cysteine. B12 status therefore shifts the balance between recycling and cysteine production. It is a regulatory relationship rather than an additive one.

5-methyltetrahydrofolate donates the methyl group that methionine synthase transfers to homocysteine, so folate status shares control of the same branch point with B12. The branch determines whether homocysteine is recycled or committed to cysteine synthesis. Formulators pair thiol donors with the methyl donors for this reason.

Betaine-homocysteine methyltransferase uses betaine as the methyl donor in a folate-independent remethylation of homocysteine, mostly in the liver and kidney. That route competes with the transsulfuration branch that produces cysteine. The pairing is common in one-carbon formulations and the interaction is direction-setting rather than additive.

Glutathione reductase is a flavoenzyme that uses FAD, derived from riboflavin, to regenerate reduced glutathione from its oxidised form. Supplying cysteine raises the amount of glutathione that can be made; riboflavin status governs how much of it stays in the reduced state. The two act at different points of the same cycle.

Glutathione reductase runs on NADPH, and NADP derives from niacin. Adequate niacin status is one of the conditions for keeping the glutathione pool reduced once cysteine supply is sufficient. This is established cofactor biochemistry and is not a claim about a measured combined outcome.

Tocopherol handles lipid-phase radicals and the resulting tocopheroxyl radical is reduced again by water-phase reductants including ascorbate and thiols. Cysteine supplied as N-acetylcysteine feeds the glutathione arm of that network. The relationship is network chemistry measured in redox markers, and a marker is not an outcome.

Free thiols reduce ferric iron to the ferrous state and can bind transition metals, so a thiol donor taken with an iron salt changes the redox state and the coordination of that iron in the gut lumen. The practical consequence is that the two are usually separated by a few hours rather than dosed together. This is flagged as an interaction worth spacing, not a warning about either ingredient.

Activated charcoal adsorbs small organic molecules indiscriminately in the gut lumen, which includes N-acetylcysteine taken by mouth. Anything given close in time to charcoal is delivered at reduced availability. Separate the two doses if both are in a regimen.